Achieve recognition of all radiotherapy professions
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma
Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
Large Language Model Influence on Diagnostic Reasoning: A Randomized Clinical Trial
Corner Editor: Philippe Lambin
Corner Editor: Evert van Limbergen